Production (Stage)
Cryo-Cell International, Inc.
CCEL
$4.83
$0.030.63%
AMEX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 128.80K | 402.10K | -8.93M | -9.30M | -9.73M |
| Total Depreciation and Amortization | 1.20M | 1.02M | 1.09M | 1.18M | 1.42M |
| Total Amortization of Deferred Charges | 21.10K | 21.20K | 21.30K | 21.40K | 21.50K |
| Total Other Non-Cash Items | 1.11M | 867.70K | 10.29M | 10.53M | 10.75M |
| Change in Net Operating Assets | 4.87M | 3.70M | 4.72M | 4.27M | 4.46M |
| Cash from Operations | 7.32M | 6.01M | 7.20M | 6.70M | 6.92M |
| Capital Expenditure | -2.01M | -2.40M | -4.11M | -7.22M | -6.92M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.82M | -2.47M | -1.63M | -1.25M | -362.80K |
| Cash from Investing | -4.82M | -4.88M | -5.74M | -8.46M | -7.28M |
| Total Debt Issued | 7.07M | 5.22M | 3.20M | 4.15M | 1.90M |
| Total Debt Repaid | -4.60M | -3.06M | -3.85M | -1.86M | -1.87M |
| Issuance of Common Stock | 76.40K | 76.40K | 1.00K | -- | -- |
| Repurchase of Common Stock | -1.25M | -1.42M | -1.42M | -1.42M | -726.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.04M | -2.02M | -- | -- | -- |
| Other Financing Activities | 228.00K | 228.00K | 228.00K | 228.00K | -67.50K |
| Cash from Financing | -2.52M | -979.10K | -1.84M | 1.11M | -761.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.00K | 154.80K | -386.60K | -654.80K | -1.13M |